Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Atossa Genetics Inc (NQ: ATOS)
3.860 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 7:59 PM EDT, Aug 6, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 3.860
Bid (Size) 3.830 (1)
Ask (Size) 3.980 (26)
Prev. Close 3.860
Today's Range 3.860 - 3.860
52wk Range 0.7500 - 5.080
Shares Outstanding 2,651,952
Dividend Yield N/A
Performance
YTD
+142.77%
+142.77%
1 Month
+7.52%
+7.52%
3 Month
+132.53%
+132.53%
6 Month
+157.33%
+157.33%
1 Year
+82.08%
+82.08%
Top News
More News
Atossa Therapeutics Receives Approval to Open Clinical Study of AT-301 Nasal Spray Being Developed to Treat COVID-19
Enrollment Expected to Begin Within 30 days Read More
from GlobeNewswire News Releases
Atossa Therapeutics Announces Findings from FDA-Approved Expanded Access Treatment with Endoxifen
Patient has taken Atossa’s Endoxifen for 18 months without side effects and without cancer recurrence Read More
from GlobeNewswire News Releases
More News
Read More
Registration Is Now Open for Atossa Therapeutics’ Tribe Public Webinar Presentation and Q&A Event on July 30, 2020
from GlobeNewswire News Releases
4 Penny Stocks To Buy For Under $4.50; For Now
from Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Avance Clinical Contracted for Atossa Therapeutics AT-301 Nasal Spray Clinical Study, Atossa's Second COVID-19 Therapeutic Development Program
from ACN Newswire
Atossa Therapeutics Contracts for Clinical Study of AT-301 Nasal Spray, Atossa’s Second COVID-19 Therapeutic Development Program
from GlobeNewswire News Releases
Atossa Therapeutics Announces Successful In Vitro Testing of Nasal Spray Formulation: AT-301 Inhibits SARS-CoV-2 Infectivity of VERO Cells in Laboratory Culture
from GlobeNewswire News Releases
First Week of ATOS September 18th Options Trading
category Stocks
from Market News Video
Why Atossa Therapeutics Is Trading Lower Today
category Market News , Health Care , ATOS , and 5 more.
from Benzinga
The Daily Biotech Pulse: Voyager, AbbVie End Collaboration, Thumbs Down For DBV's Peanut Allergy Patch, Tiziana Expedites COVID-19 Trial Plans
category ITMR , TSLA , Benzinga , and 87 more.
from Benzinga
Stocks That Hit 52-Week Highs On Monday
category NOMD , RIOT , BGS , and 276 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.